PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Cy7 anti-human/mouse/rat CD278 (ICOS), 25 μg
PE/Dazzle 594™ anti-human CD41, 100 tests
PE/Dazzle 594™ anti-human CD41, 25 tests
PE/Dazzle 594™ anti-human CD7, 100 tests
PE/Dazzle 594™ anti-human CD7, 25 tests
PE/Dazzle™ 594 anti-human B7-H4 , 100 tests
PE/Dazzle™ 594 anti-human CD10, 100 tests
PE/Dazzle™ 594 anti-human CD10, 25 tests
PE/Dazzle™ 594 anti-human CD107a (LAMP-1), 100 tests
PE/Dazzle™ 594 anti-human CD107a (LAMP-1), 25 tests
PE/Dazzle™ 594 anti-human CD115 (CSF-1R), 100 tests
PE/Dazzle™ 594 anti-human CD115 (CSF-1R), 25 tests
PE/Dazzle™ 594 anti-human CD117 (c-kit), 100 tests
PE/Dazzle™ 594 anti-human CD117 (c-kit), 25 tests
PE/Dazzle™ 594 anti-human CD11b, 100 tests
PE/Dazzle™ 594 anti-human CD11b, 25 tests